ReadyGo has developed a pen-like device that has been adapted to help with Covid-19 detection. The device allows for testing of multiple infections, including distinguishing between coronavirus and influenza, and also testing for viral conjunctivitis, herpes and dengue fever.
ReadyGo has raised €948k across 2 funding rounds from 3 investors, most recently a round in Mar 2025. Based in Bath, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-03-06 | Other | €597k | British Business Bank’s South West Investment Fund (SWIF),Maven Capital Partners | View deal → |
| 2021-06-23 | Other | €351k | Foresight Group | View deal → |
